​Zenosense, Inc. (ZENO) Lung Cancer Detection Device Trials Could Lead to Commercial Bonanza in Diagnostics Market

… treat NSCLC (non-small-cell lung cancer), the most common type of lung cancer, accounting for … in primary healthcare settings, the lung cancer detection device continuously monitors patient … manufacturing of a pre-commercial prototype lung cancer detection device and subsequently announced …